[关键词]
[摘要]
中心性浆液性脉络膜视网膜病变(CSC)是一种好发于中青年的黄斑疾病，主要特点为后极部视网膜神经上皮浆液性脱离，从而导致中心视力下降、视物变形、变色等。该病具有一定自限性，亦可反复发作。目前发病机制仍不确切，治疗存在争议，常用的治疗方法主要包括药物治疗、视网膜激光、光动力疗法(PDT)以及近年来出现的抗血管内皮生长因子(VEGF)治疗等，但对于反复发作的CSC治疗仍较棘手。文章旨在综述目前关于CSC的治疗方法，以期为临床治疗提供参考。
[Key word]
[Abstract]
Central serous chorioretinopathy(CSC)is a macular disease predominantly affecting young to middle-aged adults, characterized by serous retinal detachment in the posterior pole, leading to symptoms such as decreased central vision, visual distortion, and color changes. The disease has a certain degree of self-limitation but can recur. The pathogenesis is still uncertain and the treatment is controversial. Commonly used treatments include medication, retinal laser, photodynamic therapy(PDT)and vitreous anti-vascular endothelial growth factor(VEGF)therapy which have emerged in recent years, but the treatment of recurrent CSC is still tricky. The purpose of this article is to review the current therapeutic approaches regarding CSC, with a view to providing a reference for clinical treatment.
[中图分类号]
[基金项目]
重庆市自然科学基金面上项目(No.CSTB2023NSCQ-MSX0245)
